As per the IBEF, the chemical sector is projected to reach $300 billion by 2025, growing at an annual growth rate of 15-20% owing to the rising demand for chemicals and reduce imports in the country.

the industry has attracted FDI worth $23.89 billion during the period April 2000 to December 2019, according to data released by the Department for Promotion of Industry and Internal Trade (DPIIT).

The governmental bodies in India face certain challenges given the scale, complexity, and diversity of processes involved for delivery of varied public services.

As a result of the government’s effort and support over the years, the Indian biotechnology industry is expected to grow at a CAGR of 8.5%,

In May 2019, NITI Aayog, the think tank of the Government of India, has drawn up a plan for forming an institutional framework for AI in the country.

In India, the solar capacity has significantly increased in the last 5.5 years from 2019; around 2.6GW to over 34GW.

Installed renewable power generation capacity has gained pace over the past few years, posting a CAGR of 17.3% between the fiscal year 2016-2020.

The expenditure by government on the health sector has grown to 1.4% in 2018 from 1.2% in 2014. Further, the Indian Government has planned to increase public health spending to 2.5% of the GDP by 2025.

The global pharmaceutical industry includes biological, medicinal, and pharmaceutical products in various forms, such as tablets, capsules, ampoules, ointments, powders, solutions, and suspensions.

Indian medical device industry comprises both international and domestic market players. Accurex Bio-medical, Danaher Corp., GE Healthcare, Narang Medical, Philips Healthcare,

Indian API industry comprises a network of over 10,500 manufacturers and 3,000 pharma companies and holds the highest share in the generic drug market